Literature DB >> 27246489

Psychometric analysis and critical appraisal of the original, revised, and modified versions of the Japanese Orthopaedic Association score in the assessment of patients with cervical spondylotic myelopathy.

Julio C Furlan1,2,3, B Catharine Craven2,3.   

Abstract

OBJECTIVE Cervical spondylotic myelopathy (CSM) is the most common cause of nontraumatic spinal cord impairment and disability in the world. Given that the Japanese Orthopaedic Association (JOA) score is the most frequently used outcome measure in clinical research and practice for treating patients with CSM, this review was undertaken to comprehensively and critically evaluate the psychometric properties of the JOA score. METHODS The authors identified studies (published in the period of January 1975 to November 2015) on the psychometric properties of the original, revised, and modified versions of the JOA score in Medline, PsycINFO, Excerpta Medica dataBASE (EMBASE), American College of Physicians Journal Club, and Cochrane Database of Systematic Reviews. Additional publications were captured in a secondary search of the bibliographies in both original research articles and literature reviews identified in the original search. The JOA scores were evaluated for item generation and reduction, internal consistency, reliability, validity, and responsiveness. This review included all those versions of the JOA score whose psychometric properties had been reported in at least 2 published studies. RESULTS The primary search strategy identified 59 studies, of which 9 fulfilled the inclusion and exclusion criteria. An additional 18 publications were captured in the secondary search and included in the analysis. The key findings from the 27 studies analyzed indicated the following: 1) the original JOA score (1975) was the source for the revised JOA score (1994) and 3 modified versions (1991, 1993, and 1999 JOA scores) reported or used in at least 2 published studies; 2) the revised and modified versions of the JOA score are markedly different from each other; 3) only the revised JOA score (1994) was validated with the original JOA score; and 4) the 1975 JOA score is the most appropriate instrument for assessing patients in Asian populations (especially from Japan) because of its psychometric attributes, and the 1991 JOA score is the most appropriate version for use in Western populations. CONCLUSIONS The authors' results indicate that the original (1975), revised (1994), and modified (1991, 1993, and 1999) versions of the JOA score are substantially different from each other in terms of their content and have been incompletely examined for their psychometric properties and cultural sensitivity. Whereas the 1975 JOA score is the most appropriate version for assessing individuals from Asian populations (particularly those eating with chopsticks), the 1991 JOA score is most suitable for evaluating patients in Western populations. Nonetheless, further investigation of the psychometric properties of the 1975 and 1991 JOA scores is recommended because of a paucity of studies reporting on the responsiveness of these 2 scoring instruments.

Entities:  

Keywords:  ADL = activities of daily living; CSM = cervical spondylotic myelopathy; DTI = diffusion tensor imaging; ICC = intraclass correlation coefficient; JOA = Japanese Orthopaedic Association; Japanese Orthopaedic Association score; MCID = minimum clinically important difference; MCS = Mental Component Summary; MDI = Myelopathy Disability Index; NDI = Neck Disability Index; PCS = Physical Component Summary; QuickDASH = Quick Disabilities of the Arm, Shoulder, and Hand; ROC = receiver operating characteristic; SSEP = somatosensory evoked potential; cervical spondylotic myelopathy; psychometric properties; reliability; responsiveness; spinal disorders; validity

Mesh:

Year:  2016        PMID: 27246489     DOI: 10.3171/2016.3.FOCUS1648

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

1.  Posterior decompression and fusion versus laminoplasty for cervical ossification of posterior longitudinal ligament: a systematic review and meta-analysis.

Authors:  Ping Xu; Guo-Dong Sun; Lu Xun; Shi-Shu Huang; Zhi-Zhong Li
Journal:  Neurosurg Rev       Date:  2020-06-13       Impact factor: 3.042

2.  The Evaluation and Prediction of Laminoplasty Surgery Outcome in Patients with Degenerative Cervical Myelopathy Using Diffusion Tensor MRI.

Authors:  X Han; X Ma; D Li; J Wang; W Jiang; X Cheng; G Li; H Guo; W Tian
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

3.  Degenerative Cervical Myelopathy; A Review of the Latest Advances and Future Directions in Management.

Authors:  Jamie R F Wilson; Jetan H Badhiwala; Ali Moghaddamjou; Allan R Martin; Michael G Fehlings
Journal:  Neurospine       Date:  2019-08-26

4.  Posterior open-door laminoplasty secured with titanium miniplates vs anchors: a comparative study of clinical efficacy and cervical sagittal balance.

Authors:  Dongyue Li; Yong Hai; Xianglong Meng; Jincai Yang; Peng Yin
Journal:  J Orthop Surg Res       Date:  2019-11-28       Impact factor: 2.359

5.  Outcome Measures and Variables Affecting Prognosis of Cervical Spondylotic Myelopathy: WFNS Spine Committee Recommendations.

Authors:  Mehmet Zileli; Shradha Maheshwari; Shashank Sharad Kale; Kanwaljeet Garg; Sajesh K Menon; Jutty Parthiban
Journal:  Neurospine       Date:  2019-09-30

6.  Improving Assessment of Disease Severity and Strategies for Monitoring Progression in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 4].

Authors:  Lindsay Tetreault; Philip Garwood; Aref-Ali Gharooni; Alvaro Yanez Touzet; Laura Nanna-Lohkamp; Allan Martin; Jefferson Wilson; James S Harrop; James Guest; Brian K Kwon; James Milligan; Alberto Martinez Arizala; K Daniel Riew; Michael G Fehlings; Mark R N Kotter; Sukhvinder Kalsi-Ryan; Benjamin M Davies
Journal:  Global Spine J       Date:  2021-12-31

7.  Clinical study on improving postoperative symptoms of cervical spondylotic myelopathy by Qishe pill.

Authors:  Jinhai Xu; Xiaoning Zhou; Chen Xu; Chongqing Xu; Xing Ding; Kun Jin; Ming Yan; Junming Ma; Xuequn Wu; Jie Ye; Wen Mo; Wen Yuan
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

8.  Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM).

Authors:  Alvaro Yanez Touzet; Aniqah Bhatti; Esmee Dohle; Faheem Bhatti; Keng Siang Lee; Julio C Furlan; Michael G Fehlings; James S Harrop; Carl Moritz Zipser; Ricardo Rodrigues-Pinto; James Milligan; Ellen Sarewitz; Armin Curt; Vafa Rahimi-Movaghar; Bizhan Aarabi; Timothy F Boerger; Lindsay Tetreault; Robert Chen; James D Guest; Sukhvinder Kalsi-Ryan; Angus Gk McNair; Mark Kotter; Benjamin Davies
Journal:  BMJ Open       Date:  2022-01-19       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.